Related Experiment Video
Updated: Jun 21, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
HIV patients with psychiatric disorders are less likely to discontinue HAART
Seth Himelhoch1, Clayton H Brown, James Walkup
1Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland 21212, USA. shimelho@psych.umaryland.edu
Insights
Individuals with psychiatric disorders were less likely to stop Highly Active Antiretroviral Therapy (HAART) during the first two years of treatment. Increased mental health visits further reduced the risk of HAART discontinuation in HIV patients.
Area of Science:
- Public Health
- Infectious Diseases
- Psychiatry
Background:
- Psychiatric disorders are common among individuals with HIV.
- Adherence to Highly Active Antiretroviral Therapy (HAART) is crucial for managing HIV.
- Discontinuation of HAART can lead to treatment failure and disease progression.
Purpose of the Study:
- To investigate the association between psychiatric disorders and HAART discontinuation rates in HIV-infected individuals.
- To determine if the frequency of mental health visits influences HAART discontinuation.
Main Methods:
- Longitudinal study analyzing data from 4989 HIV patients (2000-2005).
- Discrete time survival analysis used to assess time to HAART discontinuation.
- Psychiatric diagnosis (serious mental illness, depressive disorders) and mental health visit frequency were key predictors.
Main Results:
- Patients with serious mental illness were significantly less likely to discontinue HAART in the first and second years.
- Patients with depressive disorders showed a reduced likelihood of HAART discontinuation in the first year.
- Increased mental health visits (≥6 per year) were associated with a lower risk of HAART discontinuation.
Conclusions:
- Psychiatric disorders are linked to lower rates of HAART discontinuation in the initial years of HIV treatment.
- Regular engagement with mental health services appears protective against HAART discontinuation in this population.
Objective:
We examined whether having a psychiatric disorder among HIV-infected individuals is associated with differential rates of discontinuation of HAART and whether the number of mental health visits impact these rates.
Design:
This longitudinal study (fiscal year: 2000-2005) used discrete time survival analysis to evaluate time to discontinuation of HAART. The predictor variable was presence of a psychiatric diagnosis (serious mental illness versus depressive disorders versus none).
Setting:
Five United States outpatient HIV sites affiliated with the HIV Research Network.
Patients:
The sample consisted of 4989 patients. The majority was nonwhite (74.0%) and men (71.3%); 24.8% were diagnosed with a depressive disorder, and 9% were diagnosed with serious mental illness.
Main Outcome Measures:
Time to discontinuation of HAART adjusting for demographic factors, injection drug use history, and nadir CD4 cell count.
Results:
Relative to those with no psychiatric disorders, the hazard probability for discontinuation of HAART was significantly lower in the first and second years among those with SMI [adjusted odds ratio: first year, 0.57 (0.47-0.69); second year, 0.68 (0.52-0.89)] and in the first year among those with depressive disorders [adjusted odds ratio: first year, 0.61 (0.54-0.69)]. The hazard probabilities did not significantly differ among diagnostic groups in subsequent years. Among those with psychiatric diagnoses, those with six or more mental health visits in a year were significantly less likely to discontinue HAART compared with patients with no mental health visits.
Conclusion:
Individuals with psychiatric disorders were significantly less likely to discontinue HAART in the first and second years of treatment. Mental health visits are associated with decreased risk of discontinuing HAART.
Related Concept Videos
Retrovirus Life Cycles
Psychosis: Goals of Pharmacotherapy
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Sexually Transmitted Infections
Psychological and Sociocultural Causes of Schizophrenia
Drug Therapy
Antianxiety Medications

